This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San Diego

Leslie Mitchell
Co-Founder and CEO at Neochromosome
Speaker

Profile

Leslie Mitchell is a co-founder and CEO of Neochromosome, a wholly owned subsidiary of Opentrons Labworks accelerating antibody discovery via automation-enabled yeast surface display platforms. Previously, Leslie led technology development for the Synthetic Yeast Genome project, a global consortium that built the world's first synthetic eukaryotic cell. Leslie completed a postdoctoral fellowship in synthetic genomics at Johns Hopkins and a PhD in systems biology at the University of Ottawa

Agenda Sessions

  • neoSwitch™: A Switchable Yeast Platform and Robotic Workflow for VHH & ScFv Discovery

    12:05pm